Spring 2008:features & functionality overview

Julie Gordon, Product Director

Presented at SLA DPHT Spring Meeting, St Petersburg, Florida

What does Inteleos include?

Launched in May 2006

• 10,000+ brand drug records– 16,400+ indications

– 70% in active development

• Previewing at SLA PHT– 9000+ US generic drugs

– New design

– Improved search capabilities

– Expanded content

Brand drug coverage

• Preclinical > launch > post marketing, includes associated licensing activity

• Comprehensive FDA submission & approval filings• Competitor profile • Tracking advancements in technological innovations:

– bio-specific antibodies– modified release mechanisms– gene therapy

• Detailed clinical trial coverage – summarized per drug record including links to ClinicalTrials.gov

• Full-text archive of selected articles from The Pink Sheet and links to related press releases

Straight to the information

• Search & filter features, including:– Product type, method of delivery– Discontinued by phase– Development timelines

• Flexible reporting– Analysis of data in graphical or chart displays– Multi-format exporting– Save search results– Share content with colleagues online

• Update alert– Keywords & search queries

Injection - intravenous, 10mg/ml

COMPARISON ANALYSISPIPELINE MATRIX

What’s new?

• New design

• Improved usability– Full Boolean searching

– Drug name instead of brand/generic/code

– Better organization of search and analysis pages

• Searchable development timelines

• Pharmacokinetic data for FDA approved drugs

• LINKING TO GENERIC DRUGS

• Searchable EMEA submission and approval details

Generics coverage

• FDA tentative approvals and approved generics

• Links back to brand drugs

• Continuous updates of FDA Drug Master Files

• Full indication coverage

• Identification of generic equivalencies

• Orange Book approved dosage forms

• To Come: – linked and searchable Paragraph IV data

– selected articles from The Pink Sheet

• SCREEN SHOTS

– DMF files• filter option

• export option

Inteleos

• Seamless linking between brand and generic drugs

• Comprehensive and searchable FDA and EMEA submission/approval details

• Tracking drug and biologic development

• Flexible search and export options

• Dynamic analysis tools

Thank you

For more information please visit our booth